Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$610K Hold
5,371
0.07% 228
2019
Q1
$541K Sell
5,371
-24
-0.4% -$2.18K 0.06% 239
2018
Q4
$461K Hold
5,395
0.06% 250
2018
Q3
$494K Buy
5,395
+36
+0.7% +$3.19K 0.05% 255
2018
Q2
$457K Buy
5,359
+500
+10% +$42.2K 0.05% 260
2018
Q1
$406K Hold
4,859
0.04% 272
2017
Q4
$350K Buy
+4,859
New +$334K 0.04% 290
2017
Q3
Sell
-6,769
Closed -$423K 379
2017
Q2
$423K Buy
6,769
+9
+0.1% +$532 0.05% 269
2017
Q1
$361K Buy
6,760
+810
+14% +$43.8K 0.04% 289
2016
Q4
$319K Buy
+5,950
New +$303K 0.04% 292

Other funds holding ZTS

Chemical Bank's ZTS Position: Q2 2019 in Review

Chemical Bank held its Zoetis (ZTS) position steady in Q2 2019 at 5,371 shares worth $610K. The position accounts for 0.07% of the portfolio, ranked #228.

Chemical Bank first reported a position in ZTS in Q4 2016 and has held it in 10 quarters since. 1,071 funds tracked by Wall St. Rank hold ZTS as of Q2 2019.

  • Chemical Bank held 5,371 shares of Zoetis worth $610K as of Q2 2019.
  • Chemical Bank left its Zoetis share count unchanged in Q2 2019.
  • Zoetis made up 0.07% of Chemical Bank's portfolio in Q2 2019, its #228 holding.
  • Chemical Bank first reported a position in Zoetis in Q4 2016 and has held it in 10 quarters since.
  • 1,071 funds tracked by Wall St. Rank held Zoetis as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.